Gaudium IVF's $18M IPO Fully Subscribed by Second Day of Bidding

By: WE Staff | Monday, 23 February 2026

• Gaudium IVF and Women Health issued an IPO worth $18 million
• The IPO was fully subscribed within the second day of the bidding process
• The retail investors subscribed to 2.1 times the number of shares allocated to them

Gaudium IVF and Women Health (GAUD.NS) successfully completed its Initial Public Offering (IPO) of $18 million, with the entire amount being subscribed by the second day of bidding.

Retail investors contributed the majority of the subscription, with 2.1 times the number of shares reserved for them being subscribed.

No bids were made for the portion of the offering reserved for qualified institutional investors, while non-institutional investors subscribed 1.87 times the allotted amount of shares.

When the shares are listed, Gaudium IVF will be the first fertility services company in India listed on a stock exchange. The growing acceptance of infertility treatments has led to increasing amounts of private investment into this sector.

Gaudium IVF has defined an IPO price range of 75 to 79 Rupees per Share, and the company is seeking a valuation of as much as Rs. 5.75 Billion ($63.2 Million) at the top end of this band in connection with the Offering. The IPO will include a Rs. 1.65 billion fresh issue and a Rs. 750 million offer to sell.

Meanwhile, Indira IVF, a competitor of Gaudium IVF in the fertility services sector, filed confidentially with the Securities and Exchange Board of India and received regulatory approval for its own listing late last year.